Cargando…

Exploring the Interface between Inflammatory and Therapeutic Glucocorticoid Induced Bone and Muscle Loss

Due to their potent immunomodulatory anti-inflammatory properties, synthetic glucocorticoids (GCs) are widely utilized in the treatment of chronic inflammatory disease. In this review, we examine our current understanding of how chronic inflammation and commonly used therapeutic GCs interact to regu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Webster, Justine M., Fenton, Chloe G., Langen, Ramon, Hardy, Rowan S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888251/ https://www.ncbi.nlm.nih.gov/pubmed/31744114 http://dx.doi.org/10.3390/ijms20225768

Ejemplares similares

OR09-3 11β-HSD1 Mediates a Partial Suppression of Muscle Atrophy in Chronic Inflammatory Disease in Response to Therapeutic Glucocorticoids
por: Webster, Justine, et al.
Publicado: (2019)

SAT-003 Therapeutic Glucocorticoids Prevent Local and Systemic Bone Loss but Exacerbate Muscle Wasting When Administered in Chronic Inflammation
por: Fenton, Chloe, et al.
Publicado: (2019)

Therapeutic glucocorticoids prevent bone loss but drive muscle wasting when administered in chronic polyarthritis
por: Fenton, C. G., et al.
Publicado: (2019)

Global Deletion of 11β-HSD1 Prevents Muscle Wasting Associated with Glucocorticoid Therapy in Polyarthritis
por: Webster, Justine M., et al.
Publicado: (2021)

Inflammation and Skeletal Muscle Wasting During Cachexia
por: Webster, Justine M., et al.
Publicado: (2020)

Local steroid activation is a critical mediator of the anti-inflammatory actions of therapeutic glucocorticoids
por: Fenton, Chloe, et al.
Publicado: (2021)

Endogenous Glucocorticoid Metabolism in Bone: Friend or Foe
por: Martin, Claire S., et al.
Publicado: (2021)

Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone loss
por: Kaur, K, et al.
Publicado: (2009)

Role of glucocorticoid-induced leucine zipper (GILZ) in inflammatory bone loss
por: Yang, Nianlan, et al.
Publicado: (2017)

11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy
por: Fenton, C. G., et al.
Publicado: (2019)

Glucocorticoid-Induced Osteoporosis – A Disorder of Mesenchymal Stromal Cells?
por: Hardy, Rowan, et al.
Publicado: (2011)

Bone loss: Therapeutic approaches for preventing bone loss in inflammatory arthritis
por: Rehman, Qaiser, et al.
Publicado: (2001)

Cell Transitions Contribute to Glucocorticoid-Induced Bone Loss
por: Qiao, Xiaojing, et al.
Publicado: (2023)

Synovial DKK1 expression is regulated by local glucocorticoid metabolism in inflammatory arthritis
por: Hardy, Rowan, et al.
Publicado: (2012)

Differential glucocorticoid metabolism in patients with persistent versus resolving inflammatory arthritis
por: Nanus, Dominika E, et al.
Publicado: (2015)

The therapeutic efficacy of denosumab for the loss of bone mineral density in glucocorticoid-induced osteoporosis: a meta-analysis
por: Yamaguchi, Yuta, et al.
Publicado: (2020)

Inflammatory regulation of glucocorticoid metabolism in mesenchymal stromal cells
por: Ahasan, Mohammad M, et al.
Publicado: (2012)

Bisphosphonates for Prevention of Bone Loss in Glucocorticoid-Treated Young People
por: Reid, Ian R.
Publicado: (2019)

Glucocorticoid-induced expansion of classical monocytes contributes to bone loss
por: Liu, Pei, et al.
Publicado: (2022)

Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes
por: Gado, Manuel, et al.
Publicado: (2022)

11β-HSD1 determines the extent of muscle atrophy in a model of acute exacerbation of COPD
por: Webster, Justine M., et al.
Publicado: (2023)

Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications
por: Goldring, Steven R, et al.
Publicado: (2000)

Anti-Inflammatory and General Glucocorticoid Physiology in Skeletal Muscles Affected by Duchenne Muscular Dystrophy: Exploration of Steroid-Sparing Agents
por: Herbelet, Sandrine, et al.
Publicado: (2020)

Bone Loss with Multiple Sclerosis: Effect of Glucocorticoid Use and Functional Status
por: Dabbaghmanesh, M H, et al.
Publicado: (2011)

Local and systemic glucocorticoid metabolism in inflammatory arthritis
por: Hardy, R, et al.
Publicado: (2008)

Glucocorticoid-Induced Bone Loss Is Associated with Abnormal Intravertebral Areal Bone Mineral Density Distribution
por: Manning, Louise I., et al.
Publicado: (2013)

Effectiveness of bazedoxifene in preventing glucocorticoid-induced bone loss in rheumatoid arthritis patients
por: Cho, Soo-Kyung, et al.
Publicado: (2021)

Inhibition of Cdk5 Ameliorates Skeletal Bone Loss in Glucocorticoid-Treated Mice
por: Krüger, Benjamin Thilo, et al.
Publicado: (2022)

Aurora Kinase A Regulates Cell Transitions in Glucocorticoid-Induced Bone Loss
por: Qiao, Xiaojing, et al.
Publicado: (2023)

Deletion of Mesenchymal Glucocorticoid Receptor Attenuates Embryonic Lung Development and Abdominal Wall Closure
por: Li, Aiqing, et al.
Publicado: (2013)

Therapeutic Fluorescent Hybrid Nanoparticles for Traceable Delivery of Glucocorticoids to Inflammatory Sites
por: Napp, Joanna, et al.
Publicado: (2018)

Anti-RANKL Therapy Prevents Glucocorticoid-Induced Bone Loss and Promotes Muscle Function in a Mouse Model of Duchenne Muscular Dystrophy
por: Jayash, Soher Nagi, et al.
Publicado: (2023)

11β-Hydroxysteroid Dehydrogenase Type 1 within Osteoclasts Mediates the Bone Protective Properties of Therapeutic Corticosteroids in Chronic Inflammation
por: Fenton, Chloe G, et al.
Publicado: (2022)

Let-7f-5p regulates TGFBR1 in glucocorticoid-inhibited osteoblast differentiation and ameliorates glucocorticoid-induced bone loss
por: Shen, Geng-Yang, et al.
Publicado: (2019)

Osteoblastic glucocorticoid signaling exacerbates high-fat-diet- induced bone loss and obesity
por: Kim, Sarah, et al.
Publicado: (2021)

Glucocorticoid activation by 11β‐hydroxysteroid dehydrogenase enzymes in relation to inflammation and glycaemic control in chronic kidney disease: A cross‐sectional study
por: Sagmeister, Michael S., et al.
Publicado: (2018)

Loss of the Endothelial Glucocorticoid Receptor Prevents the Therapeutic Protection Afforded by Dexamethasone after LPS
por: Goodwin, Julie E., et al.
Publicado: (2014)

Local glucocorticoid synthesis regulates house dust mite-induced airway hypersensitivity in mice
por: Merk, Verena M., et al.
Publicado: (2023)

Glucocorticoids: bad or safe for the bones?
por: Lems, Willem F
Publicado: (2015)

Glucocorticoids and Trabecular Bone Score
por: Sandru, Florica, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r6r68835m1dt723vhpsr4ak2km